Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Shares of Vertex Pharmaceuticals Inc. rose 6.92% to $463.13 Wednesday, on what proved to be an all-around positive trading ...

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) will report its first-quarter earnings on Monday. As the company reports after market hours, Wall Street expects $4.32 in EPS and $2.85 billion in revenues.

In trading on Tuesday, shares of Vertex Pharmaceuticals, Inc. (Symbol: VRTX) crossed above their 200 day moving average of $463.50, changing hands as high as $468.38 per share. Vertex Pharmaceuticals, ...

(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) reported a profit for first quarter that decreased from the same period last year and missed the Street estimates. The company's earnings came in at $646 ...

Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price target of $480.00. The company’s shares closed yesterday at ...

CHONGQING, CHINA - JULY 30: In this photo illustration, a smartphone displays the logo of Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), a global biotechnology company focused on developing therapies for ...

This was the stock's third consecutive day of losses.

Vertex Named a Premier, Inc. Breakthroughs Innovation Celebration Winner for JOURNAVX™, a First-in-Class Non-Opioid Treatment for Adults With Moderate-to-Severe Acute Pain Vertex Pharmaceuticals ...

This was the stock's fourth consecutive day of losses.